Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TheBIRC6gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis

17 Jul 2014

Abstract excerpt

// Sze Ue Iris Luk 1,2 , Hui Xue 1,2 , Hongwei Cheng 1,2 , Dong Lin 1,2 , Peter W. Gout 2 , Ladan Fazli 1 , Colin C. Collins 1 , Martin E. Gleave 1 and Yuzhuo Wang 1,2 1 The Vancouver Prostate Centre, Vancouver General Hospital and Department of Urologic Sciences, the University of British Columbia, Vancouver, BC, Canada 2 Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, Canada...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Cell death mechanisms and regulation
Share to Nuclear Structure and Function

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25071009
DOI: 10.18632/oncotarget.2229

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TheBIRC6gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosisPMID 25071009Read ↗

Exploring BIRC Family Genes as Prognostic Biomarkers and Therapeutic Targets in Prostate CancerSemantic proximity Read ↗

The mechanistic role of long non-coding RNAs in advanced prostate cancer response to therapySemantic proximity Read ↗

Exploration of the influence of GOLGA8B on prostate cancer progression and resistance of castration-resistant prostate cancer to cabazitaxelSemantic proximity Read ↗

Exploring the metastatic role of the inhibitor of apoptosis BIRC6 in Breast CancerSemantic proximity Read ↗

BIRC6 promotes hepatocellular carcinogenesis: Interaction of BIRC 6 with p53 facilitating p53 degradationSemantic proximity Read ↗

CUDC‐907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of actionSemantic proximity Read ↗

NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancerSemantic proximity Read ↗

XIAP as target for therapeutic apoptosis in prostate cancerSemantic proximity Read ↗

MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).Semantic proximity Read ↗

Signaling Pathways That Control Apoptosis in Prostate CancerSemantic proximity Read ↗

Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway–Dependent ApoptosisSemantic proximity Read ↗

Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.